
Psychemedics Investor Relations Material
Latest events

Q4 2024
23 Mar, 2025

Q3 2024
12 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Psychemedics Corporation
Access all reports
Psychemedics Corporation specializes in providing drug testing services through the analysis of hair samples for detecting drugs of abuse. This includes a broad range of substances such as cocaine, marijuana, PCP, amphetamines (including ecstasy and Adderall), opiates (like heroin and oxycodone), synthetic cannabinoids (e.g., K2 and Spice), benzodiazepines (such as Xanax and Valium), as well as nicotine, fentanyl, and alcohol. The company's testing results offer quantitative information that can indicate the approximate amount of drug ingested and historical data to show a pattern of individual drug use over time. Psychemedics' services cater to various sectors including employers for applicant and employee testing, treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation is headquartered in Dallas, Texas, and its shares are listed on the Nasdaq.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
PMD
Country
🇺🇸 United States